Estrogen News and Research

Latest Estrogen News and Research

Physical activity increases breast cancer survival

Women who reported the highest levels of physical activity in the year before they were diagnosed with breast cancer may have higher survival, according to a new study.

11 Sep 2006

Hearing loss in older women linked to hormone replacement therapy

Researchers in the U.S. are suggesting that hormone replacement therapy (HRT) may possibly exacerbate hearing deficits in women who take it following the menopause.

5 Sep 2006

Bone protection by estrens occurs through non-tissue-selective activation of the androgen receptor

A new study appearing in the September issue of the Journal of Clinical Investigation indicates that caution might be needed if a new group of drugs known as estrens are to be developed for the treatment of osteoporosis.

4 Sep 2006

Women's Health Network petitions FDA to halt sales of estrogen, testosterone combination treatments

The National Women's Health Network has petitioned FDA to stop sales of Solvay's Estratest and Breckenridge Pharmaceuticals' Syntest, which are estrogen-testosterone combination therapies used to treat menopause-associated hot flashes, until they are proven safe and effective, Reuters reports.

24 Aug 2006

Ancient blue war paint from plant rich in cancer fighting compound

Glucobrassicin, a compound in plants which is known to be an anti-cancer agent has been discovered in a plant that gave ancient Britons and Celts their blue war paint.

14 Aug 2006

Drug given to stop miscarriages doubles breast cancer risk for daughters

Scientists in the U.S. have found that the daughters of women who took a common anti-miscarriage drug during pregnancy may be facing twice the the normal risk of developing breast cancer.

8 Aug 2006

Diethylstilbestrol-exposed women at greater risk of developing breast cancer

So-called "DES daughters," born to mothers who used the anti-miscarriage drug diethylstilbestrol during pregnancy, are at a substantially greater risk of developing breast cancer compared to women who were not exposed to the drug in utero.

7 Aug 2006

Estradiol and its metabolites and their association with knee osteoarthritis

Osteoarthritis, which usually develops between the ages of 40 and 50, is more prevalent in women. It is thought that sex hormones may play a role in developing the disease, since they can be involved in inflammation of the tissues affected by it.

26 Jul 2006

Insufficient evidence exists to support the use of complementary and alternative therapies to relieve menopause

Complementary and alternative therapies show little benefit in treating menopause symptoms.

25 Jul 2006

Estrogen and testosterone combination to treat menopause may increase risk of breast cancer

Women who take a combination of estrogen and testosterone to treat the symptoms of menopause may have an increased risk of breast cancer, according to an article in the July 24 issue of Archives of Internal Medicine.

25 Jul 2006

Basal tumours may originate from breast stem cells that have undergone genetic mishaps

Findings support previous speculation that breast stem cells, or very early descendents, are the cells from which basal tumours arise.

24 Jul 2006

Endogenous sex hormones, cognitive decline and future dementia in old men

A prospective population-based study has found that higher estrogen levels in older men are associated with an increased risk of dementia. By contrast, levels of testosterone were not associated with cognitive decline.

24 Jul 2006

New natural contraceptive pill being trialled

University of Adelaide researchers, together with the Adelaide Hormone and Menopause Centre, are trialling a new natural contraceptive pill alternative.

24 Jul 2006

Most women at high risk for breast cancer do not increase their life expectancy by taking the drug tamoxifen

Tamoxifen is an extraordinarily expensive cancer-prevention strategy, costing as much as $1.3 million per year of life saved.

24 Jul 2006

Women who develop dementia start to lose weight a decade earlier

Researchers in the U.S. have discovered that prior to developing dementia, women experience a decline in weight as early as 10 years before they begin to lose their memory.

17 Jul 2006

FoxM1 regulates the expression of oestrogen receptors in breast cancer

Research just published online in the "Journal of Biological Chemistry" identifies a new molecule involved in the regulation of oestrogen receptors (ER) expression in breast cancer.

12 Jul 2006

Weight gain, particularly after menopause, is associated with increased risk of breast cancer

Weight loss after menopause lowers circulating estrogen hormones in women, and because estrogen is directly related to breast cancer, weight loss is thought to decrease risk of breast cancer.

12 Jul 2006

Combination of anastrozole and a synthetic hormone called goserelin may slow male breast cancer growth

Medical oncologists across the nation want to know whether a certain drug combination can slow the progression of male breast cancer, a rare disease that often goes undiagnosed until it's in an advanced stage.

10 Jul 2006

Gabapentin is as effective as estrogen for menopause symptoms

University of Rochester researchers, who have been investigating new therapies for hot flashes for several years, report in the July Obstetrics and Gynecology journal that the seizure drug gabapentin is as effective as estrogen

3 Jul 2006

Obesity associated with less favorable outcome after radiation therapy for prostate cancer

Obese men with prostate cancer are at higher risk for treatment failure after primary radiation therapy, according to a new study.

27 Jun 2006

Estrogen News and Research

Latest Estrogen News and Research

Physical activity increases breast cancer survival

Hearing loss in older women linked to hormone replacement therapy

Bone protection by estrens occurs through non-tissue-selective activation of the androgen receptor

Women's Health Network petitions FDA to halt sales of estrogen, testosterone combination treatments

Ancient blue war paint from plant rich in cancer fighting compound

Drug given to stop miscarriages doubles breast cancer risk for daughters

Diethylstilbestrol-exposed women at greater risk of developing breast cancer

Estradiol and its metabolites and their association with knee osteoarthritis

Insufficient evidence exists to support the use of complementary and alternative therapies to relieve menopause

Estrogen and testosterone combination to treat menopause may increase risk of breast cancer

Basal tumours may originate from breast stem cells that have undergone genetic mishaps

Endogenous sex hormones, cognitive decline and future dementia in old men

New natural contraceptive pill being trialled

Most women at high risk for breast cancer do not increase their life expectancy by taking the drug tamoxifen

Women who develop dementia start to lose weight a decade earlier

FoxM1 regulates the expression of oestrogen receptors in breast cancer

Weight gain, particularly after menopause, is associated with increased risk of breast cancer

Combination of anastrozole and a synthetic hormone called goserelin may slow male breast cancer growth

Gabapentin is as effective as estrogen for menopause symptoms

Obesity associated with less favorable outcome after radiation therapy for prostate cancer

Industry Focus: Cell & Gene Therapy eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Estrogen News and Research

Latest Estrogen News and Research

Industry Focus: Cell & Gene Therapy eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in